These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27999359)

  • 1. Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
    Hölscher ME; Bode C; Bugger H
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of diabetic cardiomyopathy.
    Bugger H; Abel ED
    Diabetologia; 2014 Apr; 57(4):660-71. PubMed ID: 24477973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy.
    Kim AH; Jang JE; Han J
    Biomed Pharmacother; 2022 Jan; 145():112463. PubMed ID: 34839258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure in diabetes.
    Jankauskas SS; Kansakar U; Varzideh F; Wilson S; Mone P; Lombardi A; Gambardella J; Santulli G
    Metabolism; 2021 Dec; 125():154910. PubMed ID: 34627874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart Failure and Diabetes: Perspective of a Dangerous Association.
    Favaloro LE; Ratto RD; Musso C
    Curr Hypertens Rev; 2021; 17(2):85-93. PubMed ID: 33823781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Established and Emerging Mechanisms of Diabetic Cardiomyopathy.
    Gollmer J; Zirlik A; Bugger H
    J Lipid Atheroscler; 2019 May; 8(1):26-47. PubMed ID: 32821697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic cardiomyopathy.
    Lee MMY; McMurray JJV; Lorenzo-Almorós A; Kristensen SL; Sattar N; Jhund PS; Petrie MC
    Heart; 2019 Feb; 105(4):337-345. PubMed ID: 30337334
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
    Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
    Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting Associations of Body Mass Index and Hemoglobin A1c on the Excess Risk of Acute Myocardial Infarction and Heart Failure in Type 2 Diabetes Mellitus.
    Edqvist J; Rawshani A; Adiels M; Björck L; Lind M; Svensson AM; Gudbjörnsdottir S; Sattar N; Rosengren A
    J Am Heart Assoc; 2019 Dec; 8(24):e013871. PubMed ID: 31818213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital admissions for cardiovascular complications of people with or without diabetes, Victoria, 2004-2016.
    Kiburg KV; MacIsaac AI; Wilson A; Sundararajan V; MacIsaac RJ
    Med J Aust; 2021 Jul; 215(2):85-86. PubMed ID: 34028039
    [No Abstract]   [Full Text] [Related]  

  • 13. Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction.
    Tromp J; Lim SL; Tay WT; Teng TK; Chandramouli C; Ouwerkerk W; Wander GS; Sawhney JPS; Yap J; MacDonald MR; Ling LH; Sattar N; McMurray JJV; Richards AM; Anand I; Lam CSP;
    Diabetes Care; 2019 Sep; 42(9):1792-1799. PubMed ID: 31292141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diabetic cardiomyopathy.
    Tarquini R; Lazzeri C; Pala L; Rotella CM; Gensini GF
    Acta Diabetol; 2011 Sep; 48(3):173-81. PubMed ID: 20198391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.
    Knapp M; Tu X; Wu R
    Acta Pharmacol Sin; 2019 Jan; 40(1):1-8. PubMed ID: 29867137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
    Seferović PM; Paulus WJ
    Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-ischemic diabetic cardiomyopathy may initially exhibit a transient subclinical phase of hyperdynamic myocardial performance.
    Hensel KO
    Med Hypotheses; 2016 Sep; 94():7-10. PubMed ID: 27515189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline.
    Julián MT; Alonso N; Lupón J; Gavidia-Bovadilla G; Ferrer E; de Antonio M; López-Ayerbe J; Domingo M; Santiago-Vacas E; Zamora E; Codina P; Moliner P; Núñez J; Santesmases J; Puig-Domingo M; Bayes-Genis A
    Cardiovasc Diabetol; 2020 Mar; 19(1):38. PubMed ID: 32293458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic cardiomyopathy: a brief summary on lipid toxicity.
    Ke J; Pan J; Lin H; Gu J
    ESC Heart Fail; 2023 Apr; 10(2):776-790. PubMed ID: 36369594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
    Tan Y; Zhang Z; Zheng C; Wintergerst KA; Keller BB; Cai L
    Nat Rev Cardiol; 2020 Sep; 17(9):585-607. PubMed ID: 32080423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.